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Abstract
The acid promoted diastereoselective dimerization of myrmicarin 215B is described. The
reactivity of these sensitive alkaloids, structural assignment, and a possible mechanism for the
observed dimerization are discussed. These finding raise the intriguing possibility of the synthesis
of the highly sensitive myrmicarin alkaloids based on a strategy involving the direct dimerization
of functional tricyclic myrmicarin derivatives.
1. Introduction
A series of structurally fascinating alkaloids have been isolated from the poison gland
secretion of the African Myrmicaria opaciventris ant species (Figure 1).1 Through a series
of elegant spectroscopic studies, the relative stereochemistry of myrmicarins 430A (1) and
663 (2) has been assigned. These complex alkaloids were found to be highly sensitive to air-
oxidation, complicating their isolation. The high sensitivity of myrmicarin 430A (1) required
its structural assignment as a crude mixture using phase-sensitive spectroscopic techniques.
1c The relative stereochemistry of myrmicarin 645 (5) in addition to the absolute
stereochemistry of complex myrmicarin alkaloids (i.e., 1, 2, and 5) is unknown. Another
isomeric myrmicarin 430 was detected in the poison gland secretion but no structural
information was reported. Interestingly, the paralytic activity of the poison gland secretion
has been attributed to these intriguing alkaloids.1b A combination of their alluring molecular
structure and the plethora of challenges associated with their sensitivity has prompted us to
initiate a program directed toward the synthesis of the complex myrmicarin alkaloids.
Herein we report our findings that raise the possibility of an efficient strategy for the
synthesis of complex myrmicarins based on a vinyl pyrrole dimerization strategy.
Schröder and Francke have reported the spontaneous dehydration of a C1′-C3 unsaturated
derivative of myrmicarin 237 (Figure 1) to give myrmicarin 217 (6),2 which they cite as
strong evidence for the formation of tricyclic myrmicarins from simpler indolizine
derivatives. Furthermore, they propose the possible dimerization of a doubly unsaturated
indolizine derivative 9 (Scheme 1) to afford myrmicarin 430A (1) and other complex
myrmicarin alkaloids.1b
While the dimerization of 9 to give myrmicarin 430A (1) is plausible, we considered the
possibility of tricyclic myrmicarin derivatives serving as direct precursors to 1. We propose
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that an acid promoted dimerization of a suitable vinyl pyrroloindolizine derivative may lead
directly to the fully substituted cyclopentane D-ring of myrmicarin 430A (1) as shown in
Scheme 2.
Specifically, our approach to the complex myrmicarin alkaloids is based on the hypothesis
that C9-protonation of myrmicarin 215B (4) by a Brönsted acid (HA) would lead to
reversible formation of the highly reactive azafulvenium ion 10 (Schemes 2 and 3).3 We
envisioned that C9-nucleophilic addition of myrmicarin 215B (4) to the C8-electrophilic
center of the proposed azafulvenium ion 10 would result in the hexacyclic azafulvenium ion
11 (Scheme 3), exchanging a π-bond for a σ-bond. Intramolecular trapping of the
intermediate azafulvenium ion 11 by C8b-nucleophilic4 addition to C1-electrophilic center
via transition state structure 12 was envisioned to give the iminium ion 13 as a heptacyclic
precursor to myrmicarin 430A (1). The C8-deprotonation of iminium ion 13 would afford
bis-enamine 14. Acid catalyzed tautomerization of the C3b-enamine would provide the
expected cis-azabicyclooctane core (the CD-ring system of 1) of myrmicarin 430A (1).
Central to this strategy for the synthesis of complex myrmicarins was our proposed acid
promoted cyclopentane annulation of vinyl pyrroloindolizine 4 (myrmicarin 215B), an
unknown mode of reactivity for vinyl pyrroles. We envisioned isolation of the highly
unstable myrmicarin 430A (1) either as an iminium ion salt (i.e. 13, Scheme 3) or as an
appropriate derivative masking the sensitive enamine functional groups.
2. Results and Discussion
2.1. Enantioselective synthesis of the tricyclic myrmicarins
The implementation of this strategy for the preparation of complex myrmicarin alkaloids
required the development of a versatile synthesis of tricyclic myrmicarin derivatives. We
have recently reported a concise, enantioselective synthesis of all tricyclic myrmicarins
(Scheme 4).5,6 The key steps involve palladium-catalyzed coupling between triflate 19 and
pyrrole 18,7,8 copper-catalyzed enantioselective conjugate reduction of the resulting N-vinyl
pyrrole 17,9,10 and a regioselective acid catalyzed Friedel-Crafts cyclization to provide the
dihydroindolizine 15 (Scheme 4).5 Hydrogenation of the C6-C7 alkene in 15 (Scheme 4)
and selective conversion of the tert-butyl ester to the corresponding primary iodide followed
by a silver tetrafluoroborate promoted cyclization provides the tricyclic ketone 20 (Scheme
5).5 The final stages of the synthesis of myrmicarin 215B (4) involved reduction of the
ketone 20 with lithium aluminum hydride at 0°C to afford the acid sensitive tricyclic alcohol
21 as an equal mixture of C8-epimers (Scheme 5). Acid catalyzed dehydration of alcohol 21
gave exclusively myrmicarin 215B (4). Alternatively, the reduction of ketone 20 to the C8-
alcohol followed by an acidic workup (pH 2) directly gave 4.5 The synthesis of the acid
sensitive C8-C9 Z-alkene of myrmicarin 215A (3) was possible by an initial dehydration of
ketone 20, using 2-chloro-3-ethylbenzoxazolium tetrafluoroborate,11 followed by partial
hydrogenation with Lindlar catalyst.5 These stereoselective routes to the vinyl
pyrroloindolizine structure provided access to the first pure samples of myrmicarins 215A
(3) and 215B (4). Complete reduction of the C3-carbonyl of 20 using lithium aluminum
hydride at high temperature provided myrmicarin 217 (6). The spectroscopic data for the
synthetic alkaloids 3, 4, and 6 were found to be identical with those reported for natural
isolates.1b
During the late operations in the synthesis of the tricyclic myrmicarins, we found the
intermediates lacking the C8-ketone to be highly sensitive to both air oxidation and acid
catalyzed decomposition. As noted in the isolation reports of myrmicarins 215 and 217,
these compounds show significant air oxidation to the corresponding C6-C7 didehydro
derivatives 213A/B and 215C.1b In fact, we observed direct conversion of benzene-d6
solutions of myrmicarins 215A, 215B, and 217 to myrmicarins 213A, 213B, and 215C,
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respectively, upon exposure to oxygen. Prolonged exposure to oxygen led to complete
decomposition of both the tricyclic myrmicarins and their dehydrogenated derivatives. As a
result, all manipulations of the tricyclic myrmicarin derivatives were conducted strictly
under an argon atmosphere.12 Indeed, as a testament to their acid sensitivity, thin layer
chromatography showed that brief exposure of myrmicarin 215A (3) to silica gel effected
partial conversion to myrmicarin 215B (4).
2.2. Acid-promoted reactivity of myrmicarin 215
As an alternative to performing an acid catalyzed C8-C9 dehydration using an acidic
aqueous work-up, completely stereoselective conversion of the alcohol 21 (~1:1, C8-
epimers) to myrmicarin 215B (4) was achieved by treatment of a benzene-d6 solution
(0.05M) of alcohol 21 with acetic acid (1.5 equiv) at ambient temperature. 1H NMR
monitoring of the reaction mixture led to the detection of the intermediate C8-acetate 22,
likewise as an approximately equal mixture of C8-epimers. After 1h, trace amounts of
myrmicarin 215B (4) were detected. Consumption of approximately 90% of the alcohol 21
occurred in 9 h, at which point an equal mixture of acetate 22 and myrmicarin 215B (4) was
observed. After an additional 61 h, myrmicarin 215B (4) was the only significant component
remaining in the sample. Failure to detect the putative azafulvenium ion 23 by 1H NMR is
consistent with its expected high reactivity and short lifetime.3
In contrast, treatment of a benzene-d6 solution (0.05M) of alcohol 21 with trifluoroacetic
acid (TFA, 1.10 equiv) effected full and clean conversion (≥90% by 1H and 13C NMR) to a
single new product within 45 min. 1H NMR (500 MHz) monitoring of the reaction mixture
revealed that myrmicarin 215B (4) was formed immediately upon introduction of TFA and
persisted in rapidly diminishing quantities until complete conversion to the new compound
had occurred. Attempts to isolate this product after proper work-up or by direct
crystallization were not successful due to rapid decomposition. However, under strictly
moisture- and oxygen-free atmosphere the reaction mixture could be stored at subambient
temperatures for 24 h without significant decomposition. 13C NMR (125 MHz) showed this
compound to possess 30 chemically distinct carbons, the number expected for the desired
dimerization product. Importantly, the same dimeric product could be obtained cleanly
(≥90% by 1H NMR) by direct treatment of a benzene-d6 solution (0.05M) of myrmicarin
215B (4) with TFA (1.10 equiv). 1H NMR (500 MHz) monitoring of a benzene-d6 solution
(0.05M) of myrmicarin 215B (4) with substoichiometric quantities of TFA revealed the
extent of the conversion to the dimeric product was approximately equal to the amount of
Brönsted acid additive, suggesting an acid promoted dimerization. By comparison,
monitoring a dilute benzene-d6 solution (0.003M) of myrmicarin 215B (4) exposed to a
large excess of TFA (>100 equiv) gave less than 5% of the dimeric product. Instead we
observed a mixture of pyrrole-ring protonated species over a period of several days.13,14 A
basic work-up returned the starting myrmicarin 215B (4). Under these conditions, the
neutral myrmicarin 215B (4) required to serve as the nucleophile in the dimerization process
was not present in sufficient concentration for the reaction to occur. Notably, the
dimerization of myrmicarin 215B (4) proceeds at low concentrations (i.e. 0.005 M) in the
presence of stoichiometric quantities of acid.
Significantly, subjection of myrmicarin 215A (3) to these dimerization conditions (benzene-
d6, 0.01M, 23 °C, 5.5h) provided a compound that was identical by 1H NMR to the dimeric
product obtained from myrmicarin 215B (4). While a trace amount of myrmicarin 215B (4)
was observed immediately after treatment with TFA, the monomer persisting throughout the
reaction was exclusively myrmicarin 215A (3), suggesting that the C8-C9-alkene
isomerization was slower than the subsequent acid promoted dimerization of myrmicarin
215B (4). Interestingly, the major myrmicarin 215 isomer isolated from the poison gland
secretion is myrmicarin 215A (3) and not myrmicarin 215B (4).1b
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2.3. Synthesis and isolation of dimeric myrmicarins
Due to the aforementioned instability of the acid promoted dimerization product of
myrmicarin 215B (4) toward isolation, we attempted to assign its structure using a
combination of gradient correlation (gCOSY) and heteronuclear single quantum correlation
(HSQC) NMR experiments. Hence, we found the C30-dimeric compound to possess four
methyl, thirteen methylene, and five methine units, as well as eight quaternary carbons.
Compellingly, all of the resonances in the 1H NMR spectrum occurred in the upfield region
(<δ3.57 ppm), attesting to the absence of the C8-C9 alkene present in the monomeric
myrmicarins 215A (3) and 215B (4). Furthermore, the 1H and 13C NMR spectra contained
one subset of that closely matched those of the tricyclic portion of myrmicarin 217 (6).
Considering the intermediates in our proposed acid promoted dimerization of myrmicarin
215B (4), we speculated that the immediate dimeric product might be related to the iminium
ion 13 (Scheme 3), a protonated tautomer of myrmicarin 430A (1). As the instability of the
immediate dimerization product precluded an aqueous work-up, chromatographic
purification, or crystallization, we examined reaction conditions that would provide a more
stable, isolable derivative for thorough characterization.
Addition of hydrogen cyanide to a solution of the dimeric product to trap the putative
iminium ion did not provide a stable derivative.15 We reasoned that introduction of mild
reducing agents would result in reduction of a reactive iminium ion or enamine functional
group(s) that may be present in the dimerization product (i.e., C8a-iminium ion 13 or bis-
enamine 14, Scheme 3). Interestingly, sequential treatment of a benzene solution (0.02 M) of
either alcohol 21 or myrmicarin 215B (4) with TFA (1.10 equiv) for 4h at 23°C followed by
addition of sodium triacetoxyborohydride (6.50 equiv) in acetonitrile and mixing of the
mixture (3.5:1, benzene:acetonitrile) for 3.5 hours at 23°C, provided a compound with
sufficient stability to undergo aqueous work-up (saturated aqueous ammonium hydrogen
chloride solution), isolation, and chromatographic purification on silica gel. Significantly,
this oxygen-sensitive compound obtained in 66% isolated yield as a single diastereomer was
consistent in all respects (HR-CIMS, 1H, 13C, gCOSY, HSQC) with the hexacyclic dimer 24
(Scheme 7). The isolation of the dimer 24 as the sole product suggests a highly
diastereoselective dimerization of myrmicarin 215B (4) in the initial bond forming event.
The C2- and C3-stereochemistry was later shown to be (2S,3R), as described below. The
isolation of compound 24 is consistent with hydride reduction at C1 in either azafulvenium
ion 11 (Scheme 3) or iminium ion 13 (Scheme 3).16
Although evidence for the first of the two carbon-carbon bond forming events in our
proposed dimerization was compelling, we required a means of isolating a suitable
derivative of the putative heptacyclic iminium ion to validate the formation of the second
carbon-carbon bond, and to secure the presence of the fully substituted cyclopentane. The
difficulties in the full structural characterization of the immediate TFA promoted
dimerization product (due to its limited longevity) notwithstanding, in situ NMR correlation
experiments of this compound provided valuable information. Importantly, while the
assignment of all thirty signals in the 13C NMR spectrum agreed reasonably well with the
predicted values based on those of myrmicarin 430A (1), the resonance assigned to position
C8b in the putative iminium ion 13 (Scheme 4) occurred at an anomalously high chemical
shift (δ96.1 ppm). As this value was higher than expected for a quaternary carbon, we
systematically considered alternative structures that would be more consistent with the data
for the putative iminium ion (Scheme 8). While the anticipated C1-C8b bond formation
would result in the heptacyclic iminium ion 13 (Scheme 8, path A), an alternate bond
formation between C1 and C3b would provide the isomeric heptacyclic iminium ion 25
(Scheme 8, path B).17 In this scenario, the signal at δ96.1 ppm would be due to the C3b in
the iminium ion 25 (Scheme 8).
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The spectroscopic data that we had obtained for the heptacyclic iminium ion was more
consistent with a C1-C3b second bond formation to yield 25 (Scheme 8). To firmly establish
the connectivity of the heptacyclic dimerization product, we investigated possible
derivatives for further spectroscopic analysis. We reasoned that C8-deprotonation of the
putative intermediate 25 (Scheme 8) with a strong base would provide the corresponding
enamine that may exhibit enhanced stability relative to the iminium ion 25. Gratifyingly, we
found that treatment of a benzene-d6 solution of the dimeric iminium ion, prepared as
described above, with excess resin-bound BEMP (2-tert-butylimino-2-diethylamino-1,3-
dimethyl-perhydro-1,3,2-diazaphosphorine, 10 equiv) under strictly oxygen-free conditions
cleanly yielded a new C30-product as a solution in benzene-d6. Importantly, the 1H NMR
(500 MHz) of this species possessed a single resonance at δ4.72 ppm (1H, dd), which was
consistent with an expected C8-methine of enamine 27 (Scheme 9, for stereochemical
assignment see Figure 2). Addition of methanol-d4 (15 equiv) to the solution of enamine 27
resulted in complete disappearance of the resonance at δ4.72 ppm over a period of 1.5 h,
consistent with the 2H/H-exchange of an enamine. Unfortunately, the enamine 27 was
unstable toward an aqueous work-up or attempted purification. While this presented
challenges with regard to isolation or derivatization of enamine 27, its sensitivity was not
surprising based on the reported difficulties associated with the closely related myrmicarin
430A (1). However, an isolable derivative could be obtained by hydrogenation (1 atm of
dihydrogen over 5% palladium on carbon) of the diene 27 in benzene, which cleanly
afforded the enamine 28.18 Thus without the need for isolation of sensitive intermediates,
alcohol 21 was converted to enamine 28 in a single operation (87%).19 Enamine 28 was
sufficiently stable toward isolation in neat form but required storage under strictly inert
atmosphere to avoid oxidative decomposition.
Similar to the previously isolated hexacycle 24 (Scheme 7), the 1H and 13C NMR spectra of
both diene 27 and enamine 28 contained one set of resonances that closely resembled those
of the tricyclic core of myrmicarin 217 (6). Furthermore, the 13C and 1H-13C HSQC NMR
spectra of each compound showed the correct number of methine, methylene, methyl, and
quaternary carbon units for structures 27 and 28 (Scheme 9). The presence of distinct C4-C8
and C1-C3 spin systems was recognized in the gCOSY spectra of both diene 27 and
enamine 28. However, this data alone was not sufficient to distinguish between the two
modes of cyclization (path A versus path B, Scheme 8) in the formation of these heptacyclic
products. Additional data obtained using heteronuclear multiple bond correlation (HMBC)
and nuclear Overhauser effect spectroscopy (NOESY) NMR (600 MHz) experiments
allowed structural verification of products 27–29 (Scheme 9). The HMBC correlations
(Figure 2A) in the spectrum of the enamine 28 were entirely consistent with the heptacyclic
structure depicted in Scheme 9 (path B, Scheme 8). Correlations between C1-H/C4-Hc, C3a-
H/C4-Ht, and C3a-H/C11-H in the NOESY spectrum of enamine 28 validated this structural
assignment. Additionally, NOESY correlations between C1-H/C10′-H, C2-H/C3-H, and
C3a/C9 provided the relative stereochemistry about the newly formed fully substituted
cyclopentane ring (Figure 2B).20
We also sought derivatives that would be amenable to X-ray crystallographic analysis.
Unfortunately, numerous attempts to crystallize the enamine 28 were unsuccessful. Even
under strictly inert conditions extensive decomposition was observed within two days.
Similar complications were present during manipulations of the corresponding protonated
salts of enamine 28 formed upon treatment of 28 with a variety of Brönsted acids. In
attempts to obtain derivatives with greater stability, we found that treatment of a benzene
solution of the enamine 27 (Scheme 9) with benzoyl chlorides in the presence of excess
diisopropylethylamine cleanly provided the corresponding C8-benzoylated products, many
of which could be purified by silica gel chromatography. For example, in a single operation,
the C8-p-bromobenzoylated product 29 was obtained in 67% yield starting with the alcohol
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21 without isolation of iminium ion 26 or diene 27. Although the C8-p-bromobenzoylated
and C8-p-iodobenzoylated products were found to be storable in the absence of oxygen,
crystallization and co-crystallization attempts did not provide samples suitable for single
crystal X-ray analysis. However, 2D-NMR analysis of these samples provided additional
data that paralleled our earlier results with the enamine 28 (Figure 2). Specifically, the data
obtained using the isolable p-bromobenzoylated product 29 (gCOSY, HSQC, HMBC, and
NOESY) provided further support for the structural assignment of compounds 26–29. The
signals at 96.1, 86.4, 83.6, and 86.9 ppm in the 13C NMR spectra of 26–29, respectively,
were consistent with the C3b-tertiary amine. Since the hexacyclic dimer 24 is obtained by
treatment of the iminium ion intermediate 26 with sodium triacetoxyborohydride, the C2-
and C3-stereochemistry of 24 is assignment based on the relative stereochemistry found in
the heptacyclic compounds 26–29.
A possible mechanism for the dimerization of myrmicarin 215B (4) to enamine 27 is
presented in Scheme 10. The overall process may involve a stepwise C9-C8 bond formation
to give 30 followed by C3b-C1 bond formation to provide the iminium ion 31.21 The
relative stereochemistry of the newly formed cyclopentane ring that is shared in compounds
26–29 suggests a convex face to convex face approach (i.e., 30, Scheme 10). Under the
reaction conditions described above, π-stacking interactions between the putative electron
deficient azafulvenium ion 10 and the approaching electron rich vinyl pyrroloindolizine (4),
or the positioning of the counter ion (A−, Scheme 10) with respect to the dimerization
precursors may be responsible for the observed stereoselectivity. Hence, ongoing efforts are
directed at modifying the reaction conditions and identifying an appropriate counter ion (i.e.
formate) that may influence the mode of dimerization (Scheme 8). While the involvement of
any biosynthetic machinery in the dimerization of C15 myrmicarin monomers to the more
complex myrmicarins is unknown at this time, the observed high level of diastereoselection
and efficiency in our acid promoted dimerization of myrmicarin 215B (4) highlights the
possible direct dimerization of a pyrroloindolizine (i.e. 4) as the first step toward C30 and
C45 derivatives.
3. Conclusions
TFA-promoted dimerization of (+)-myrmicarin 215B (4) leads to a sequence of highly
efficient and stereoselective carbon-carbon bond forming events, providing the heptacyclic
dimeric enamine 27 (Scheme 9). A possible mechanism for the diastereoselective
dimerization of myrmicarin 215B (4) to this isomer of myrmicarin 430A (1), isomyrmicarin
430A (27), is presented (Scheme 10). The isolation of a single diastereomer of the
heptacyclic products via the TFA promoted dimerization of myrmicarin 215 is noteworthy.
These observations provide experimental data relevant to our proposed vinyl
pyrroloindolizine dimerization strategy for the synthesis of the heptacyclic portion of
complex myrmicarin alkaloids. Current efforts are directed at controlling the mode of
dimerization (Scheme 8) for implementation of this strategy toward these highly sensitive
compounds: a strategy with potential implications regarding the biogenesis of these
structurally fascinating alkaloids.
4. Experimental Section
4.1. General Procedures
Reactions were performed in oven-dried or flame-dried round bottomed flasks or modified
Schlenk (Kjeldahl shape) flasks. The flasks were fitted with rubber septa and reactions were
conducted under a positive pressure of argon. NMR experiments were performed in
vacuum-dried Wilmad Glass Co., Inc. 528-PP NMR tubes. Stainless steel syringes or
cannulae were used to transfer air- and moisture-sensitive liquids. Flash column
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chromatography was performed as described by Still22 using silica gel (60-Å pore size, 32–
63 μm, standard grade, Sorbent Technologies) or non-activated alumina gel (80–325 mesh,
chromatographic grade, EM Science). Analytical thin-layer chromatography was performed
using glass plates pre-coated with 0.25 mm 230–400 mesh silica gel or neutral alumina gel
impregnated with a fluorescent indicator (254 nm). Thin layer chromatography plates were
visualized by exposure to ultraviolet light and/or by exposure to an ethanolic
phosphomolybdic acid (PMA), an acidic solution of p-anisaldehyde (anis), an aqueous
solution of ceric ammonium molybdate (CAM), an aqueous solution of potassium
permanganate (KMnO4) or an ethanolic solution of ninhydrin followed by heating (<1 min)
on a hot plate (~250 °C). Organic solutions were concentrated on Büchi R-200 rotary
evaporators at ~20 Torr (house vacuum) at 25–35 °C, then at ~1 Torr (vacuum pump) unless
otherwise indicated. Commercial reagents and solvents were used as received with the
following exceptions: Dichloromethane, diethyl ether, tetrahydrofuran, acetonitrile and
toluene was purchased from J.T. Baker (Cycletainer™) and were purified by the method of
Grubbs et al. under positive argon pressure.23 Proton nuclear magnetic resonance (1H NMR)
spectra were recorded with a Varian inverse probe 500 INOVA spectrometer or a Bruker
inverse probe 600 Avance spectrometer. Chemical shifts are recorded in parts per million
from internal tetramethylsilane on the δ scale and are referenced from the residual protium
in the NMR solvent (C6H6: δ7.16). Data is reported as follows: chemical shift [multiplicity
(s = singlet, d = doublet, q = quartet, m = multiplet), coupling constant(s) in Hertz,
integration, assignment]. Carbon-13 nuclear magnetic resonance spectra were recorded with
a Varian 500 INOVA spectrometer and are recorded in parts per million from internal
tetramethylsilane on the δ scale and are referenced from the carbon resonances of the solvent
(benzene-d6: δ 128.0). We thank Dr. Li Li for obtaining HRMS data at the Department of
Chemistry Instrumentation Facility (MIT-DCIF). Infrared data were obtained with a Perkin-
Elmer 2000 FTIR and are reported as follows: [frequency of absorption (cm−1), intensity of
absorption (s = strong, m = medium, w = weak, br = broad), assignment].
4.2.1. Tricyclic alcohol 21
Solid lithium aluminum hydride (11.6 mg, 306 μmol, 6.00 equiv) was added in a single
portion to a solution of tricyclic ketone 20 (11.8 mg, 51.0 μmol, 1 equiv) in Et2O (950 μL) at
−78 °C followed by immediate placement of the reaction flask on an ice-water bath. After
40 min, the vigorously stirred grey suspension was cooled to −78 °C and excess hydride was
quenched by the slow addition of water (1.20 mL) via syringe. The cold bath was
immediately removed and the mixture allowed to warm to 23 °C. The pale grey suspension
was diluted sequentially with a 6-mL portion of Et2O and a saturated aqueous solution of
Rochelle salt (6 mL), and the two-phase mixture was vigorously stirred. After 3h, the
resulting slightly opaque aqueous layer was separated from the clear and colorless organic
layer and was extracted with EtOAc (3×5 mL). The combined organic layers were washed
with a 5-mL portion of brine, dried over anhydrous sodium sulfate, filtered, and
concentrated under reduced pressure to give exclusively the alcohol 21 as a colorless oil
(10.9 mg, 100%). 1H NMR analysis revealed the product to be a mixture of C8-epimers
(3:2). The alcohol 21 was found to be exceedingly sensitive toward dehydration and
decomposition upon treatment with silica or alumina gel and required storage under an
argon atmosphere. 1H NMR (500 MHz, C6D6, 23°C, 3:2 mixture of epimers, major epimer
denoted by *), δ: 4.71 (dd, 1H, J = 7.6, 5.8 Hz, C8-H*), 4.70 (dd, 1H, J = 7.2, 6.3 Hz, C8-
H), 3.19–3.27 (m, 2H, C4a-H*, C4a-H), 2.74 (dd, 1H, J = 14.6, 7.9 Hz, C7-H*), 2.53–2.70
(m, 9H, C3-H*, C3-H, C3-H*, C3-H, C11-H*, C11-H, C11-H’*, C11-H’, C7-H), 2.31–2.41
(m, 2H, C7-H*, C7-H), 2.00–2.09 (m, 2H, C4-H*, C4-H), 1.90–1.99 (m, 4H, C9-H*, C9-H,
C9-H’*, C9-H’), 1.65–1.72 (m, 2H, C6-H, C6-H), 1.50–1.60 (m, 4H, C4-H*, C4-H, C5-H*,
C5-H), 1.31 (t, 3H, J = 7.5 Hz, C12-H*), 1.28 (t, 3H, J = 7.6 Hz, C12-H), 1.12 (t, 3H, J =
7.3 Hz, C10-H), 1.11 (t, 3H, J = 7.3 Hz, C10-H*), 0.79–0.90 (m, 2H, C5-H*, C5-H). 13C
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NMR (500 MHz, C6D6, 23°C, 3:2 mixture of epimers, major epimer denoted by *), δ:
127.7*, 127.6, 121.6*, 121.6, 118.9*, 118.5, 118.3*, 118.3, 70.0*, 69.7, 55.3*, 55.2, 37.2*,
37.4, 31.5*, 32.4, 30.2*, 30.2, 26.3*, 26.3, 23.2*, 23.1, 20.9*, 20.9, 19.2*, 19.1, 17.2*, 17.3,
11.8, 11.7*. FTIR (neat), cm−1: 3417 (br-s, O-H), 2597 (s, C-H), 2854 (s, C-H), 1454, 1320,
1044. HRMS (ESI): m/z calcd for C15H23NONa [M + Na]+: 256.1672; Found: 256.1677.
TLC (alumina gel, 30% EtOAc-hexanes), Rf: 0.26, 0.30 (UV, KMnO4).
4.2.2. Hexacyclic dimer 24
A sample of alcohol 21 (3.4 mg, 14.6 μmol, 1 equiv) was dried by concentration from
anhydrous benzene-d6 (3×350 μL). The residue was dissolved in benzene-d6 (650 μL) and
was purged by a stream of argon for 3 min. A solution of TFA (1.2 μL, 16.0 μmol, 1.10
equiv) in benzene-d6 (51.2 μL) was added drop wise via syringe. The resulting solution
became intense yellow immediately upon addition of TFA and faded to a tan color within 2
min. The mixture was mixed and maintained under an argon atmosphere for 4.5 h. A
suspension of sodium triacetoxyborohydride (20.1 mg, 94.9 μmol, 6.50 equiv) in
acetonitrile-d3 (200 μL) was then added via syringe and the resulting pale burgundy
suspension was stirred under inert atmosphere. After 3.5h, the suspension was diluted with
EtOAc (7.5 mL) and the resulting mixture was washed with saturated aqueous ammonium
chloride solution (4 mL). The clear, colorless aqueous layer was separated and extracted
with ethyl acetate (3×3 mL) and the combined pale yellow organic solution was washed
with saturated aqueous sodium bicarbonate (3 mL), and brine (3 mL). The organic layer was
dried over anhydrous sodium sulfate, and then concentrated under reduced pressure to give a
deep brown residue. Purification of the residue by silica gel column chromatography (5%
EtOAc-hexanes; diameter 0.5 cm, height 4.5 cm) gave the hexacyclic dimer 24 as a yellow
oil (2.1 mg, 66%).24 1H NMR (500 MHz, C6D6, 23 °C), δ: 3.36 (m, 2H, C4a’-H, C5a’-H),
3.15 (dd, 1H, J = 13.4, 2.7 Hz, C1-H), 2.80 (m, 1H, C3-H), 2.79 (m, 1H, C3′-H/C4-H),
2.63–2.73 (m, 9H, C3′-H/C4-H, C11-H, C11′-H, C3′-H/C4-H, C7′-H, C8-H, C3′-H/C4-H),
2.46 (m, 2H, C7′-H, C8-H), 2.35 (dd, 1H, J = 13.4, 10.8 Hz, C1-H’), 2.20 (m, 1H, C2-H),
2.06 (m, 1H, C4′-H/C5-H), 2.01 (m, 1H, C4′-H/C5-H), 2.01 (m, 1H, C9-H), 1.93 (m, 1H,
C9-H’), 1.71 (m, 2H, C6′-H/C7-H), 1.67 (m, 1H, C4′-H/C5-H), 1.59 (m, 1H, C4′-H/C5-H),
1.57 (m, 2H, C5′-H, C6-H), 1.46 (t, 3H, J = 7.5 Hz, C12-H/C12′-H), 1.43 (t, 3H, J = 7.5 Hz,
C12-H/C12′-H), 1.42 (m, 1H, C6′-H/C7-H), 1.35 (m, 1H, C6′-H/C7-H), 1.26 (d, 3H, J = 6.7
Hz, C10′-H), 1.11 (t, 3H, J = 7.3 Hz, C10-H), 0.91 (m, 1H, C5′-H/C6-H), 0.88 (m, 1H, C5′-
H/C6-H). 13C NMR (125.8 MHz, C6D6, 23 °C), δ: 128 (C2a’/C3b), 126.8 (C2a’/C3b), 122.7
(C1′/C8b), 121.8 (C1′/C8b), 118.6 (C7a’/C8a), 118.3 (C7a’/C8a), 116.5 (C2′/C3a), 114.1
(C2′/C3a), 55.4 (C4a’/C5a), 55.2 (C4a’/C5a), 44.9 (C3), 42.1 (C2), 37.6 (C4′, C5), 31.3
(C1), 30.6 (C5′/C6), 30.3 (C5′/C6), 27.4 (C3′/C4), 25.6 (C3′/C4), 25.2 (C9), 23.3 (C6′/C7),
23.2 (C6′/C7), 21.3 (C7′/C8), 21.2 (C7′/C8), 19.3 (C11/C11′), 19.3 (C11/C11′), 18.2 (C10′),
17.0 (C12, C122′), 13.8 (C10). FTIR (neat), cm−1: 2928 (s, C-H), 2852 (s, C-H), 1737, 1688,
1458, 1321, 1261, 1197. HRMS (ESI): m/z calcd for C30H44N2 [M+H]+: 433.3577; Found:
433.3441. TLC (silica gel, 10% EtOAc-hexanes), Rf: 0.53 (UV, anis).
4.2.3. Iminium salt 26
A sample of myrmicarin 215B (4, 5.5 mg, 25.6 μmol, 1 equiv) was dried by concentrated
from anhydrous benzene (3×350 μL). The residue was dissolved in benzene-d6 (600 μL) in
an NMR tube fitted with a rubber septum and was purged by a gentle stream of argon for 3
min. A solution of TFA (2.2 μL, 29.4 μmol, 1.15 equiv) in benzene-d6 (52.7 μL) was added
drop-wise via syringe. The resulting reaction mixture became intense yellow immediately
upon addition of the TFA solution and gradually turned brown over 30 min. The sample was
mixed and maintained under an argon atmosphere for 4.5 h at ambient temperature. 1H
NMR analysis revealed complete conversion of myrmicarin 215B (4) to the highly air-
sensitive iminium salt 26. This compound was found to be unstable toward isolation. The
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same dimerization product 26 was obtained starting with the alcohol 21 in place of
myrmicarin 215B (4) following a similar protocol. 1H NMR (500 MHz, C6D6, 23 °C), δ:
3.57 (tdd, 1H, J = 10.5, 4.9, 3.7 Hz, C4a’-H), 2.82 (m, 1H, C8-H), 2.77 (m, 1H, C8-H’), 2.73
(m, 1H, C5a-H), 2.54 (m, 1H, C7′-H), 2.54 (d, 1H, J = 9.8 Hz, C1-H), 2.45 (m, 1H, C11′-H),
2.39 (m, 1H, C11′-H’), 2.35 (m, 1H, C3-H), 2.34 (m, 1H, C4′-H), 2.31 (m, 1H, C5-H), 2.29
(m, 1H, C7′-H), 2.29 (m, 1H, C2-H), 2.29 (m, 1H, C3′-H), 2.24 (q, 2H, J = 7.6 Hz, C11-H),
2.05 (tdd, 1H, J = 14.3, 10.7, 6.3 Hz, C3′-H), 1.81 (m, 1H, C7-H), 1.68 (m, 1H, C6′-H), 1.68
(m, 1H, C5-H), 1.64 (m, 1H, C5′-H), 1.60 (m, 1H, C4′-H), 1.54 (m, 1H, C4-H), 1.47 (m, 1H,
C4-H’), 1.45 (m, 1H, C6′-H), 1.35 (m, 1H, C6-H), 1.29 (m, 1H, C9-H), 1.22 (m, 1H, C7-
H’), 1.19 (t, 3H, J = 7.5 Hz, C12′-H), 1.08 (m, 1H, C9-H’), 1.06 (t, 3H, J = 7.6 Hz, C12-H),
0.88 (m, 1H, C6-H’), 0.81 (t, 3H, J = 7.5 Hz, C10-H), 0.77 (m, 1H, C5′-H), 0.74 (d, 3H, J =
6.7 Hz, C10′-H). 13C NMR (125.8 MHz, C6D6, 23 °C), δ: 187.1 (C8a), 181.0 (C3a), 137.2
(C8b), 127.1 (C2a’), 121.7 (C1′), 119.4 (C7a’), 111.3 (C2′), 96.1 (C3b), 55.7 (C5a), 55.6
(C4a’), 51.7 (C2), 45.9 (C1), 45.2 (C3), 38.0 (C4), 37.7 (C4′), 36.7 (C5), 29.7 (C5′), 27.0
(C6), 27.0 (C3′), 26.4 (C8), 22.7 (C6′), 21.0 (C9), 20.9 (C7′), 18.6 (C7), 18.6 (C11′), 18.3
(C11), 17.1 (C12′), 16.7 (C10′), 14.0 (C12), 13.3 (C10).
4.2.4. Heptacyclic diene 27
A sample of alcohol 21 (5.1 mg, 21.9 μmol, 1 equiv) was dried by concentration from
anhydrous benzene (3×350 μL). The residue was dissolved in benzene-d6 (600 μL) in an
NMR tube fitted with a rubber septum and was purged by a gentle stream of argon for 3
min. A solution of TFA (1.8 μL, 24.1 μmol, 1.10 equiv) in benzene-d6 (52.1 μL) was added
drop wise via syringe. The resulting reaction mixture became intense yellow immediately
upon addition of the TFA and faded to a tan color within 2 min. The sample was mixed and
maintained under an argon atmosphere for 4.5 h at ambient temperature. Monitoring of the
reaction mixture by 1H NMR revealed complete consumption of alcohol 21 and myrmicarin
215B (4, generated in situ). The contents of the sample were transferred to a recovery flask
under an inert atmosphere (glove-box, nitrogen atmosphere) and the transfer completed with
three 50-μL benzene-d6 rinses. A single portion of resin-bound BEMP (99.0 mg, 2.2 μmol/
mg on 200–400 mesh polystyrene resin, 10.0 equiv) was added to the solution of the
iminium salt 26 and the resulting pale yellow suspension was stirred for 30 min under
strictly inert conditions. The suspension was filtered through a cotton plug, the filter-cake
was rinsed with benzene-d6 (3×150 μL), and the pale yellow solution was sealed in a
recovery flask under a nitrogen atmosphere, placed on a vacuum manifold and concentrated
to ~350 μL. The transfer of this solution via cannula into a sealed, argon-purged NMR tube
and using two additional portions of benzene-d6 (150 μL) to complete the transfer, provided
a clear, faintly yellow solution of the exceedingly air-sensitive diene 27 suitable for 1H
NMR and 13C NMR analysis. 1H NMR (500 MHz, C6D6, 23 °C), δ: 4.72 (dd, 1H, J = 7.2,
3.2 Hz, C8-H), 3.46 (tdd, 1H, J = 10.9, 5.4, 3.8 Hz, C4a’-H), 3.00 (m, 1H, C3′-H), 3.00 (m,
1H, C5a-H), 2.70 (dd, J = 15.4, 7.5 Hz, 1H, C3′-H), 2.68 (m, 1H, C7′-H), 2.67 (q, 2H, J =
7.6 Hz, C11′-H), 2.60 (d, 1H, J = 10.7 Hz, C1-H), 2.50 (ddd, 1H, J = 16.0, 11.8, 6.3 Hz, C7′-
H), 2.48 (m, 1H, C3-H), 2.34 (dq, 1H, J = 13.8, 7.5 Hz, C11-H), 2.26 (dq, 1H, J = 13.8, 7.5
Hz, C11-H’), 2.26 (m, 1H, C2-H), 2.21 (m, 1H, C7-H), 2.16 (m, 1H, C5-H), 2.15 (m, 1H,
C7-H’), 2.08 (dt, 1H, J = 11.5, 5.8 Hz, C4′-H), 1.85 (td, 1H, J = 11.5, 7.8 Hz, C4-H), 1.75
(m, 1H, C4-H’), 1.71 (m, 1H, C6-H), 1.69 (m, 1H, C6′-H), 1.68 (m, 1H, C5-H’), 1.65 (m,
1H, C4′-H), 1.53 (m, 1H, C5′-H), 1.50 (m, 1H, C9-H), 1.39 (m, 1H, C6′-H), 1.38 (t, 3H, J =
7.6 Hz, C12′-H), 1.31 (m, 1H, C9-H’), 1.24 (t, 3H, J = 7.5 Hz, C12-H), 1.09 (tdd, 1H, J =
11.9, 4.9, 1.4 Hz, C6-H’), 1.04 (d, 3H, J = 6.7 Hz, C10′-H), 1.00 (t, 3H, J = 7.3 Hz, C10-H),
0.88 (tdd, 1H, J = 12.8, 10.9, 2.0 Hz, C5′-H). 13C NMR (125.8 MHz, C6D6, 23 °C), δ: 152.9
(C8a), 152.3 (C3a), 132.7 (C8b), 128 (C2a’), 121.9 (C1′), 116.7 (C7a’), 114.2 (C2′), 88.0
(C8), 86.4 (C3b), 55.5 (C4a’), 54.8 (C5a), 50.3 (C2), 49.4 (C1), 44.8 (C3), 41.3 (C4), 37.3
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(C4′), 36.2 (C5), 30.6 (C6), 30.2 (C5′), 27.9 (C3′), 23.3 (C6′), 22.7 (C7), 21.3 (C7′), 20.8
(C9), 19.4 (C11), 19.2 (C11′), 17.6 (C12′), 16.3 (C10′), 14.8 (C12), 13.9 (C10).
4.2.5. Heptacyclic Enamine 28
A sample of alcohol 21 (10.0 mg, 42.9 μmol, 1 equiv) was dried by concentration from
anhydrous benzene (3×500 μL). The residue was dissolved in benzene (1.06 mL) and was
purged by a stream of argon for 3 min. A solution of TFA (3.5 μL, 47.2 μmol, 1.10 equiv) in
benzene (23.5 μL) was added drop-wise via syringe. The resulting solution became intense
yellow immediately upon addition of TFA and faded to a clear tan color within 2 min. The
mixture was mixed and maintained under an argon atmosphere for 4.5 h. The contents of the
sample were transferred to a recovery flask under an inert atmosphere (glove-box, nitrogen
atmosphere) and the transfer completed with three 50-μL benzene-d6 rinses. A single portion
of resin-bound BEMP (195 mg, 2.2 μmol/mg on 200–400 mesh polystyrene resin, 10.0
equiv) was added to the solution of the iminium ion salt 26 and the resulting pale yellow
suspension was stirred for 30 min under strictly inert conditions. The suspension was filtered
through a cotton plug and the filter-cake was rinsed with benzene (3×450 μL) to give a
solution of the diene 27. Palladium on activated carbon (20.0 mg, 5%-Pd/C) was added and
the flask was sealed under nitrogen and removed from the glove-box. The reaction vessel
was flushed with dihydrogen (~1 atm) for 5 min and then maintained under a balloon-
pressure of dihydrogen for an additional 30 min at ambient temperature. Dilution of the
black suspension with EtOAc (2 mL), and filtration of the mixture through a plug of celite
(diam 0.6 cm, ht. 4.0 cm), followed by an EtOAc rinse (15 mL), yielded a clear yellow
solution of the desired enamine 28. Removal of the volatiles under reduced pressure gave
the pure enamine 28 (8.1 mg, 87%) as a clear yellow oil with marginal stability. This
enamine was sufficiently stable toward isolation in neat form but required storage under
strictly inert atmosphere to avoid oxidative decomposition; spectroscopic characterization
was conducted shortly after isolation. 1H NMR (500 MHz, C6D6, 23 °C), δ: 3.54 (tdd, 1H, J
= 10.7, 5.5, 3.6 Hz, C4a’-H), 3.10 (ddd, 1H, J = 15.3, 10.9, 5.9 Hz, C3′-Hc), 2.92 (s, 1H,
C3a-H), 2.87 (dd, 1H, J = 15.3, 7.6 Hz, C3′-Ht), 2.85 (d, 1H, J = 12.8 Hz, C1-H), 2.68 (m,
1H, C2-H), 2.68 (m, 1H, C11′-H), 2.66 (m, 1H, C11′-H), 2.65 (m, 1H, C5a-H), 2.64 (m, 1H,
C7′-Hc), 2.47 (ddd, 1H, J = 15.9, 11.8, 6.4 Hz, C7′-Ht), 2.38 (dt, 1H, J = 14.4, 4.2 Hz, C8-
Ht), 2.26 (dq, 1H, J = 14.3, 7.3 Hz, C11-H), 2.17 (dt, 1H, J = 10.7, 5.7 Hz, C4′-Hc), 2.14 (td,
1H, J = 11.9, 7.6 Hz, C4-Hc), 2.05 (dq, 1H, J = 14.3, 7.3 Hz, C11-H’), 1.90 (m, 1H, C4-Ht),
1.90 (m, 1H, C8-Hc), 1.81 (tdd, 1H, J = 13.6, 5.5, 4.7 Hz, C6-Hc), 1.72 (m, 1H, C3-H), 1.71
(m, 1H, C6′-Ht), 1.70 (m, 1H, C4′-Ht), 1.67 (m, 1H, C9-H), 1.63 (m, 1H, C5′-Hc), 1.56 (td, J
=11.7, 3.6 Hz, 1H, C5-Ht), 1.51 (dddd, J = 13.5, 5.2, 3.2, 1.9, 1H, C6-Ht), 1.42 (m, 1H, C7-
Hc), 1.41 (m, 1H, C6′-Hc), 1.34 (t, 3H, J = 7.5 Hz, C12′-H), 1.25 (m, 1H, C9-H’), 1.24 (m,
1H, C7-Ht), 1.14 (t, 3H, J = 7.3 Hz, C12-H), 1.07 (t, 3H, J = 7.3 Hz, C10-H), 1.06 (m, 1H,
C5-Hc), 1.03 (d, 1H, J = 7.0 Hz, C10′-H), 0.96 (tdd, 1H, J = 12.8, 10.7, 2.4 Hz, C5′-Ht). 13C
NMR (125.8 MHz, C6D6, 23 °C), δ: 140.5 (C8a), 128 (C2a’), 123.2 (C1′), 117.4 (C7a’),
114.8 (C8b), 111.2 (C2′), 83.6 (C3b), 62.0 (C3a), 58.8 (C5a), 55.5 (C4a’), 51.9 (C1), 50.1
(C3), 40.1 (C2), 38.2 (C4), 37.5 (C4′), 30.5 (C5′), 28.6 (C3′), 28.0 (C5), 27.7 (C6), 24.9
(C8), 23.3 (C6′), 22.9 (C9), 21.3 (C7′), 20.6 (C7), 19.9 (C11), 19.3 (C11′), 17.3 (C12′), 14.9
(C12), 14.7 (C10′), 13.6 (C10). HRMS (ESI): m/z calcd for C30H44N2 [M+H]+: 433.3577;
Found: 433.3566. TLC (silica gel pre-treated with Et3N, 1.5% Et3N, 2.5% EtOAc-hexanes),
Rf: 0.27 (UV, anis).
4.2.6. Bromophenylketone 29
A sample of alcohol 21 (9.6 mg, 41.2 μmol, 1 equiv) was dried by concentration from
anhydrous benzene (3×500 μL). The residue was dissolved in benzene (1.0 mL) and was
purged by a stream of argon for 3 min. A solution of TFA (3.4 μL, 45.3 μmol, 1.10 equiv) in
benzene (25.0 μL) was added drop-wise via syringe. The pale yellow mixture became
Ondrus and Movassaghi Page 10
Tetrahedron. Author manuscript; available in PMC 2010 July 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
intense yellow immediately upon addition of TFA and faded to a clear tan color solution
within 2 min. The reaction mixture was mixed and maintained at ambient temperature for
4.5 h under strictly inert atmosphere to allow complete conversion of the myrmicarin 215B
(4) to the iminium ion 26. A single portion of resin-bound BEMP (187 mg, 2.2 μmol/mg on
200–400 mesh polystyrene resin, 10.0 equiv) was added under an inert atmosphere (glove-
box, nitrogen atmosphere) to the solution of the iminium salt 26 and the resulting pale
yellow suspension was stirred under strictly inert conditions. After 30 min, the yellow
suspension was filtered through a cotton plug into a recovery flask and the transfer was
completed using additional benzene (3×450 μL) as a rinse. The flask was sealed under
nitrogen and removed from the glove-box. The pale yellow solution was concentrated
partially under reduced pressure (to ~750 μL). Diisopropylethyamine (89.7 μL, 515 μmol,
12.5 equiv) was added via syringe at ambient temperature, followed by 4-bromobenzoyl
chloride (11.3 mg, 51.5 μmol, 1.25 equiv) as a solid in a single portion and the flask was
immediately resealed and flushed with argon. The resulting intense yellow, slightly opaque
mixture was vigorously stirred at ambient temperature. After 30 min, diisopropylamine (150
μL, 1.07 mmol, 26.1 equiv) was introduced via syringe to quench the excess acid chloride.
After 5 min, the suspension was concentrated under reduced pressure to give the crude
product as a bright yellow semi-solid. Purification of the residue by column chromatography
on silica gel (5% Et3N, 5% EtOAc-hexanes, diameter 1.5 cm, height 15 cm) afforded the
benzoylated derivative 29 as a bright yellow oil (8.4 mg, 67%). 1H NMR (500 MHz, C6D6,
23 °C), δ: 7.67 (d, 2H, J = 8.2 Hz, C15-H, C15′-H), 7.29 (d, 2H, J = 8.2 Hz, C16-H, C16′-
H), 3.48 (tdd, 1H, J = 10.7, 5.0, 3.7 Hz, C4a’-H), 3.16 (dq, 1H, J = 14.0, 7.3 Hz, C11-H),
2.80 (m, 1H, C5a-H), 2.78 (m, 1H, C3′-Hc), 2.65 (m, 1H, C3′-Ht), 2.62 (m, 1H, C7′-Hc),
2.59 (m, 2H, C11′-H), 2.48 (m, 1H, C3-H), 2.44 (m, 1H, C7′-Hc), 2.38 (dt, 1H, J = 13.8, 3.3
Hz, C7-Ht), 2.25 (m, 1H, C11-H’), 2.24 (td, 1H, J = 13.8, 2.9 Hz, C7-Hc), 2.20 (m, 1H, C2-
H), 2.15 (m, 1H, C5-Ht), 2.13 (m, 1H, C4′-Hc), 1.69 (m, 1H, C6′-Ht), 1.65 (m, 1H, C4-Hc),
1.63 (m, 1H, C4′-Ht), 1.61 (m, 1H, C4-Ht), 1.56 (m, 1H, C5′-Hc), 1.52 (m, 1H, C5-Hc), 1.44
(m, 1H, C9-H), 1.43 (m, 1H, C6-Hc), 1.38 (m, 1H, C6′-Hc), 1.32 (t, 3H, J = 7.6 Hz, C12′-H),
1.23 (m, 1H, C9-H’), 1.19 (t, 3H, J = 7.3 Hz, C12-H), 0.95 (d, 3H, J = 6.7 Hz, C10′-H), 0.93
(t, 3H, J = 7.6 Hz, C10-H), 0.89 (tdd, 1H, J = 12.6, 10.4, 2.2 Hz, C5′-Ht), 0.82 (dtd, 1H, J =
13.8, 11.9, 2.9 Hz, C6-Ht). 13C NMR (125.8 MHz, C6D6, 23 °C), δ: 190.4 (C13), 162.6
(C3a), 162.6 (C8a), 141.8 (C14), 136.6 (C8b), 131.8 (C15), 131.4 (C16), 128 (C2a’), 125.2
(C17), 122.0 (C1′), 117.5 (C7a’), 113.6 (C2′), 104.2 (C8), 86.9 (C3b), 55.6 (C4a’), 54.6
(C5a), 49.4 (C2), 48.5 (C1), 45.1 (C3), 41.0 (C4), 37.3 (C4′), 36.7 (C5), 30.4 (C6), 30.1
(C5′), 28.8 (C7), 27.5 (3′), 23.2 (C6′), 21.2 (C7′), 20.9 (C11), 20.8 (C9), 19.0 (C11′), 17.4
(C12′), 16.3 (C10′), 14.8 (C12), 13.6 (C10). HRMS (ESI): m/z calcd for C37H45BrN2O [M
+H]+: 613.2788; Found: 613.2771. TLC (silica gel, 20% EtOAc-hexanes), Rf: 0.41 (UV,
ninhydrin).
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Figure 1.
Representative members of the myrmicarin family of alkaloids. aThe relative
stereochemistry of 5 is unknown; see reference 1d.
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Figure 2.
Key HMBC (1H→13C) and NOESY correlations for the enamine 28.
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Scheme 1.
Francke’s proposed dimerization of bicyclic diene 9 to give myrmicarin 430A (1).
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Scheme 2.
Our proposed potential biomimetic dimerization of pyrroloindolizines to give of myrmicarin
430A (1).
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Scheme 3.
Our proposed dimerization of myrmicarin 215B (4) to give 1.
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Scheme 4.
Synthesis of key bicyclic intermediate 15.
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Scheme 5.
Enantioselective synthesis of the tricyclic myrmicarin alkaloids.
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Scheme 6.
Acetic acid catalyzed dehydration of alcohol 21 to myrmicarin 215B (4).
Ondrus and Movassaghi Page 21
Tetrahedron. Author manuscript; available in PMC 2010 July 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Scheme 7.
Acid promoted dimerization of myrmicarin 215B (4) followed by immediate reduction to
provide the first isolable dimeric product 24. The C2- and C3-stereochemistry was later
assigned; see below.
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Scheme 8.
Two possible modes of intramolecular azafulvenium ion trapping leading to isomeric
heptacyclic iminium ions 13 and 25.
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Scheme 9.
TFA promoted dimerization of myrmicarin 215B (4) and related derivtives. For
stereochemical assignment please see below. (a) TFA, benzene-d6, 23 °C, 3h, □90%. (b)
NaBH(OAc)3, MeCN-d3, benzene-d6, 23 °C, 3.5h, 68% from 21. (c) resin bound-BEMP,
benzene-d6, 23 °C, 30 min. (d) methanol-d4 (~15 equiv), benzene-d6, 23 °C, 1.5h, complete
C8 deuterium incorporation. (e) Pd/C, H2, 87% from 21. (f) p-BrPhCOCl, 30 min; iPr2NH,
67% from 21.
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Scheme 10.
The proposed mechanism for the diastereoselective dimerization of (+)-myrmicarin 215B
(4) to an isomer of myrmicarin 430A (1), enamine 27 (isomyrmicarin 430A).
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